Sun Li, Hu Juan, Feng Yingdi, Dai Qianhuan. Clinical Development of the Anticancer Platinum Complex[J]. Journal of Beijing University of Technology, 1999, 25(1): 120-127.
Citation:
Sun Li, Hu Juan, Feng Yingdi, Dai Qianhuan. Clinical Development of the Anticancer Platinum Complex[J]. Journal of Beijing University of Technology, 1999, 25(1): 120-127.
Sun Li, Hu Juan, Feng Yingdi, Dai Qianhuan. Clinical Development of the Anticancer Platinum Complex[J]. Journal of Beijing University of Technology, 1999, 25(1): 120-127.
Citation:
Sun Li, Hu Juan, Feng Yingdi, Dai Qianhuan. Clinical Development of the Anticancer Platinum Complex[J]. Journal of Beijing University of Technology, 1999, 25(1): 120-127.
Clinical Development of the Anticancer Platinum Complex
The clinical results of new anticancer platinum complexes-Oxaliplatin Lobaplatin, Ormaplatin, 254-S, TRK710 and DWA 2114R are reviewed on their activity and toxicity in this paper. It is suggested that Oxaliplatin is a promising anticancer drugs for its panticular effectiveness toward anticancer, compared with Cis-platin and Carboplatin.
DownLoad: